NEW YORK (Reuters) - Merck & Co on Wednesday said it had provided U.S. regulators with new information needed for approval to market ...
BOSTON (Reuters) - An experimental vaccine cured nearly half of women with pre-cancerous growths on their genitals, producing major improvement in nearly four ...
FDA approves Merck's cervical cancer vaccine Gardasil to prevent genital warts in boys Drugmaker Merck said Friday that U.S. regulators cleared its vaccine Gardasil to prevent genital warts in boys, a new use for a product already approved to prevent cervical cancer ...
CHICAGO (Reuters) - Vaccinating boys against the virus that causes cervical cancer and genital warts does not appear to be cost-effective, U.S. researchers said on Thursday. Assuming all girls get the shot, adding boys to a national vaccination program may not be ...
WASHINGTON (Reuters) - GlaxoSmithKline Plc's bid to sell its Cervarix cervical cancer vaccine in the United States faced further delay on Tuesday and the company recalled a batch of the vaccine in Britain following a teenager's death. The U.S. Food and Drug ...
CDC: Rhode Island has highest HPV vaccination rate, Mississippi the lowest One in three teenage girls have rolled up their sleeves for a vaccine against cervical cancer, but vaccination rates vary dramatically between states, according to a federal report released Thursday. The ...
GAITHERSBURG, Maryland (Reuters) - Merck & Co's cervical cancer vaccine is safe and effective for preventing genital warts in males ages 9 to 26, a U.S. advisory panel said on Wednesday. The Gardasil vaccine has already been approved for girls and young ...
Drugmaker Merck likely will face U.S. competition for its vaccine Gardasil, after federal experts recommended rival GlaxoSmithKline's Cervarix also be approved to prevent the virus that causes most cervical cancers. The FDA's panel of vaccine experts voted overwhelmingly Wednesday that Cervarix appears ...
Glaxo's Cervarix vaccine moves towards US approval, Merck's Gardasil wins backing for boys Drugmaker Merck likely will face U.S. competition for its vaccine Gardasil, after federal experts recommended rival GlaxoSmithKline's Cervarix also be approved to prevent the virus that causes most cervical ...
GAITHERSBURG, Maryland (Reuters) - Merck & Co's cervical cancer vaccine is safe and effective for preventing genital warts in males ages 9 to 26, a U.S. advisory panel said on Wednesday. The Gardasil vaccine has already been approved for girls and young ...
FDA panel says Merck vaccine for cervical cancer Gardasil blocks genital warts in males Federal health advisers say Merck's vaccine Gardasil, which already is used to prevent cervical cancer in women, should also be approved to stop genital warts in men. A ...
GAITHERSBURG, Maryland (Reuters) - GlaxoSmithKline PLC's proposed cervical cancer vaccine is safe and effective for girls and young women ages 10 to 25, a U.S. advisory panel said on Wednesday. The endorsement from Food and Drug Administration advisers moves the Cervarix vaccine ...
